EUVIMEDEUVIMED entdecken
Open Access

CD34 + PI16 + fibroblast progenitors aggravate neointimal lesions of allograft arteries via CCL11/CCR3-PI3K/AKT pathway

Xiaodong Xu, Pengwei Zhu, Han Wang, Kai Chen, Liang Liu, Luping Du, Liujun Jiang, Yanhua Hu, Xuhao Zhou, Bohuan Zhang, Xiangyuan Pu, Xiaosheng Hu und 3 weitere

Theranostics · 2025

DOI: 10.7150/thno.104650 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Xiaodong Xu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Neointima, Antigens, CD34, Fibroblasts, Chemokine CCL11. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Transplant-accelerated arteriosclerosis is a common complication that limits the long-term survival of organ transplant recipients. While previous studies have indicated the involvement of CD34+ stem/progenitor cells (SPCs) in this process, their heterogeneity and potential adverse effects remains incompletely understood.

Methods

To investigate the role of CD34+ SPCs in transplant arteriosclerosis, we used various genetically modified mouse models, including BALB/c, C57BL/6J, CD34-CreERT2, Rosa26-tdTomato, Rosa26-iDTR, CD34-Dre, PI16-CreERT2, and CAG-LSL-RSR-tdTomato-2A-DTR mice. Single-cell RNA sequencing (scRNA-seq), chemokine antibody microarrays, ELISA assays, and immunohistochemistry were employed to identify fibroblast progenitors and their interactions with smooth muscle cells. Furthermore, in vivo and in vitro experiments targeting the CCL11/CCR3-PI3K/AKT signaling pathway were conducted to assess its role in the pathogenesis of transplant arteriosclerosis.

Results

Single-cell RNA-seq and genetic lineage tracing revealed a subpopulation of fibroblast progenitors, characterized by high CD34 and PI16 expression, which differentiated into a distinct chemotactic fibroblast subset. Proteomic and scRNA analysis revealed that this CD34+ PI16- subgroup released CCL11 (Eotaxin-1), which promoted intimal hyperplasia through the paracrine activation of smooth muscle cells. Binding of CCL11 to its receptor CCR3 activated the PI3K/AKT signaling pathway in smooth muscle cells, driving their proliferation and migration. In vivo, overexpression of CCL11 promoted neointimal hyperplasia, while neutralizing CCL11 or inhibiting CCR3 alleviated neointimal formation.

Conclusions

These findings identified CD34+ PI16+ fibroblast progenitors that differentiate into specific chemotactic fibroblasts, releasing chemokines pivotal for neointima formation, suggesting a therapeutic strategy targeting their chemotactic activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeointimaAntigens, CD34FibroblastsChemokine CCL11Stem CellsAnimalsMiceReceptors, CCR3Proto-Oncogene Proteins c-aktSignal TransductionPhosphatidylinositol 3-KinasesMice, Inbred BALB CMice, Inbred C57BLAllograftsDisease Models, AnimalArteriosclerosisMaleMyocytes, Smooth MuscleMice, Transgenic

Stichwörter der Autor:innen

CCL11CD34+ PI16+ fibroblast progenitorsgenetic lineage tracingsmooth muscle cellstransplant arteriosclerosis

Substanzen

Receptors, CCR3Proto-Oncogene Proteins c-aktAntigens, CD34Phosphatidylinositol 3-KinasesChemokine CCL11Ccr3 protein, mouseCcl11 protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • School of Engineering and Materials Science, Queen Mary University of London, United Kingdom.
  • Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Department of Cardiology, and Institute for Cardiovascular Development and Regenerative Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Department of Cardiovascular Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Zitieren

APA

Xu, X., Zhu, P., Wang, H., Chen, K., Liu, L., Du, L., Jiang, L., Hu, Y., Zhou, X., Zhang, B., Pu, X., Hu, X., Xu, Q., Zhang, L., & Li, W. (2025). CD34 + PI16 + fibroblast progenitors aggravate neointimal lesions of allograft arteries via CCL11/CCR3-PI3K/AKT pathway. Theranostics. https://doi.org/10.7150/thno.104650

Vancouver

Xu X, Zhu P, Wang H, Chen K, Liu L, Du L, et al. CD34 + PI16 + fibroblast progenitors aggravate neointimal lesions of allograft arteries via CCL11/CCR3-PI3K/AKT pathway. Theranostics. 2025. doi:10.7150/thno.104650

BibTeX
@article{Xu2025,
  author = {Xu, Xiaodong and Zhu, Pengwei and Wang, Han and Chen, Kai and Liu, Liang and Du, Luping and Jiang, Liujun and Hu, Yanhua and Zhou, Xuhao and Zhang, Bohuan and Pu, Xiangyuan and Hu, Xiaosheng and Xu, Qingbo and Zhang, Li and Li, Weidong},
  title = {CD34 + PI16 + fibroblast progenitors aggravate neointimal lesions of allograft arteries via CCL11/CCR3-PI3K/AKT pathway},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.104650}
}
Kostenlos starten →